Catalog

Availability on request

Cartalax is an experimental short peptide belonging to the Russian/Eastern European "bioregulatory peptide" system; it is primarily marketed for its effects on cartilage, joints, and connective tissue. Key areas of focus include cartilage metabolism and protection, joint health, the promotion of connective tissue repair, anti-inflammatory effects, and age-related cartilage degeneration.

Availability on request

Livagen (KEDA; Lys-Glu-Asp-Ala) belongs to the Khavinson system of short-peptide bioregulators developed in Russia and is typically classified as a "liver/hepatocyte bioregulatory peptide." Its primary functions include protecting hepatocytes, application in liver aging research, modulating antioxidant and stress responses, and regulating chromatin.

Availability on request

Bronchogen belongs to the Khavinson system of tissue-specific short-peptide bioregulators developed in Russia and is generally identified as the tetrapeptide Ala-Glu-Asp-Leu (AEDL). Its primary functions include the protection and repair of bronchial epithelium, modulation of pulmonary inflammation, remodeling of lung tissue, and regulation of DNA and gene expression.

Availability on request

Cardiogen (AEDR; Ala-Glu-Asp-Arg) is a short peptide belonging to the Khavinson system (developed in Russia) that targets the heart and myocardium; its primary function is the bioregulation of myocardial tissue.

Availability on request

Cortagen (AEDP) is an experimental tetrapeptide compound belonging to the Khavinson family; its sequence is typically designated as Ala-Glu-Asp-Pro (AEDP). Research into this compound focuses primarily on the cerebral cortex, neuroprotection, and neuroregeneration. Its functions include neural repair/regeneration, protection of brain tissue, effects related to the cerebral cortex, and gene/chromatin regulation.

Availability on request

Testagen (KEDG: Lys-Glu-Asp-Gly) is a tetrapeptide belonging to the Khavinson family; it is primarily marketed as a bioregulatory peptide that supports male reproductive system and testicular function, as well as testosterone production. Its effects include promoting testosterone synthesis, improving male gonadal function, supporting prostate and urinary system health, and regulating DNA and gene expression.

Availability on request

Pancragen (KEDW) is a short peptide targeting the pancreas, developed within the Khavinson system; it is specifically the tetrapeptide Lys-Glu-Asp-Trp (KEDW). Research on this peptide primarily focuses on islet function, insulin and blood glucose metabolism, and age-related decline in pancreatic function. Its key areas of action include islet and pancreatic cell function, blood glucose regulation, insulin metabolism, and age-related pancreatic function.

Availability on request

Prostamax (KEDP; Lys-Glu-Asp-Pro) is an experimental tetrapeptide from the Khavinson series designed for the prostate. Its primary effects include the regulation of prostate tissue, modulation of inflammation-related processes, influence on chromatin and gene expression, and mitigation of age-related changes in the prostate.